TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development ...Middle East

Appointment builds on CHF 10 million seed financing and Board leadership expansion BASEL, Switzerland, Jan. 29, 2026 /PRNewswire/ -- TECregen, a biotechnology company pioneering thymus rejuvenation, today announced the appointment of Dr. Klaas P. Zuideveld, Ph.D., as Chief Executive...

Hence then, the article about tecregen appoints drug development veteran dr klaas p zuideveld as chief executive officer to lead thymus regeneration platform into clinical development was published today ( Thursday 29/01/2026 - 11:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development )

Also on site :

• US cybersecurity chief leaked sensitive files to ChatGPT – Politico
• Merz rejects Zelensky’s ‘concrete date’ for EU membership
• Driver ‘intentionally’ rams car into synagogue in New York (VIDEO)